AAngiotech Pharmaceuticals

Angiotech Pharmaceuticals: annual report for the year ended Mar 13, 2009

Form

10-K

Filed

Mar 16, 2009, 4:11 pm ET

Period

Mar 13, 2009

Importance

Notable

Accession

0001176256-09-000230

Document

10-K

Exhibit 4.3

Shareholder rights plan agreement dated October 30, 2008

Exhibit 10.3

Amendment to license agreement dated September 24, 2004

Exhibit 10.5

Distribution and license agreement dated April 1, 2003

Exhibit 10.6

Manufacturing and supply agreement dated April 1, 2003

Exhibit 10.9

Amendment No. 2 to distribution and license agreement dated October 8, 2007

Exhibit 10.10

Agreement and plan of merger dated May 25, 2006

Exhibit 10.11

License agreement dated November 19, 1997

Exhibit 10.12

First amendment to license agreement dated March 28, 2002

Exhibit 10.13

Second amendment to license agreement dated May 23, 2007

Exhibit 10.14

License agreement dated August 1, 1997

Exhibit 10.15

Amendment to licence agreement dated February 27, 2004

Exhibit 10.16

Form of indemnification agreement for officers ??? US

Exhibit 10.17

Form of indemnification agreement for officers ??? canada

Exhibit 10.18

Form of indemnification agreement for directors

Exhibit 10.19

Executive employment agreement dated April 23, 2004

Exhibit 10.20

Executive employment agreement dated August 8, 2007

Exhibit 10.21

Executive employment agreement dated October 30, 2007

Exhibit 10.22

Executive employment agreement dated October 15, 2007

Exhibit 10.23

Executive employment agreement dated October 15, 2007

Exhibit 10.24

Executive employment agreement dated December 17, 2007

Exhibit 10.25

Executive employment agreement dated November 26, 2007

Exhibit 10.27

2004 stock option plan

Exhibit 10.28

2006 stock option plan

Exhibit 10.29

American Medical Instruments Holdings, Inc. 2003 stock option plan